Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 15, 2023

BUY
$0.2 - $0.35 $65 - $113
325 Added 40.63%
1,125 $0
Q1 2023

May 12, 2023

SELL
$0.2 - $0.49 $247 - $607
-1,239 Reduced 60.77%
800 $0
Q4 2022

Feb 13, 2023

BUY
$0.25 - $15.6 $317 - $19,780
1,268 Added 164.46%
2,039 $0
Q3 2022

Nov 14, 2022

SELL
$0.76 - $15.98 $28 - $591
-37 Reduced 4.58%
771 $1,000
Q2 2022

Aug 12, 2022

SELL
$0.86 - $1.53 $24,178 - $43,015
-28,115 Reduced 97.21%
808 $1,000
Q1 2022

May 16, 2022

SELL
$1.15 - $2.25 $22,867 - $44,741
-19,885 Reduced 40.74%
28,923 $43,000
Q4 2021

Feb 14, 2022

SELL
$2.04 - $3.59 $53,649 - $94,413
-26,299 Reduced 35.02%
48,808 $106,000
Q3 2021

Nov 15, 2021

BUY
$3.53 - $5.89 $255,084 - $425,623
72,262 Added 2539.96%
75,107 $268,000
Q2 2021

Aug 16, 2021

SELL
$3.77 - $6.0 $81,914 - $130,368
-21,728 Reduced 88.42%
2,845 $16,000
Q1 2021

May 13, 2021

SELL
$2.39 - $6.5 $254,243 - $691,457
-106,378 Reduced 81.23%
24,573 $128,000
Q4 2020

Feb 09, 2021

BUY
$1.38 - $2.63 $124,493 - $237,260
90,213 Added 221.45%
130,951 $313,000
Q3 2020

Nov 05, 2020

SELL
$1.2 - $1.89 $11,136 - $17,539
-9,280 Reduced 18.55%
40,738 $56,000
Q2 2020

Aug 13, 2020

SELL
$1.91 - $3.45 $96,445 - $174,207
-50,495 Reduced 50.24%
50,018 $96,000
Q1 2020

May 14, 2020

BUY
$1.76 - $3.02 $176,902 - $303,549
100,513 New
100,513 $247,000

Others Institutions Holding OCX

About Oncocyte Corp


  • Ticker OCX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,609,000
  • Market Cap $260M
  • Description
  • OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....
More about OCX
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.